Ganna Bilousova

University Of Colorado Denver

$780,301

Attributed

$1,184,291

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $594K · FY2019–20

$1M$750K$500K$250K$0

'19

'20

Funding mix

By agency

NIH$1,184,291 · 2

By mechanism

U01$807,981 · 1

R21$376,310 · 1

Top collaborators

Dennis Roop2 shared

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Stem Cell Differentiation”

Tomasz Nowakowski · University Of California, San Francisco$14,641,615
Daniel Lucas · Cincinnati Childrens Hosp Med Ctr$8,016,664
Jessica Elaine Young · University Of Washington$6,043,139
Geoffrey Roger Hill · Fred Hutchinson Cancer Center$5,690,418
Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,632,967
Faranak Fattahi · University Of California, San Francisco$5,599,368

Research focus

Stem Cell DifferentiationSkin GraftEpidermolysis BullosaSourceKeratinocyteSkinClinical TrialsEffective TherapyEpidermolysis Bullosa DystrophicaInheritedBullaBaseProductionSafetyClinicCell Differentiation ProcessCellsCollagen Type ViiCell TherapyBackBiopsyInduced Pluripotent Stem CellCicatrixStem Cells

Grant awards (4)

Exploring Alternative iPS Cell Therapies for Recessive Dystrophic Epidermolysis Bullosa$419,231

U01 · FY2020 · AR

MicroRNA-based purification of keratinocytes derived from pluripotent stem cells for the treatment of skin diseases$171,050

R21 · FY2020 · AR · contact PI

Exploring Alternative iPS Cell Therapies for Recessive Dystrophic Epidermolysis Bullosa$388,750

U01 · FY2019 · AR

MicroRNA-based purification of keratinocytes derived from pluripotent stem cells for the treatment of skin diseases$205,260

R21 · FY2019 · AR · contact PI